CREATIVE REALITIES INC (CREX)

US22530J3095 - Common Stock

3.35  +0.21 (+6.69%)

Fundamental Rating

3

Taking everything into account, CREX scores 3 out of 10 in our fundamental rating. CREX was compared to 96 industry peers in the Media industry. CREX may be in some trouble as it scores bad on both profitability and health. CREX is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year CREX has reported negative net income.
CREX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
In multiple years CREX reported negative operating cash flow during the last 5 years.

1.2 Ratios

CREX has a Return On Assets of -4.16%. This is in the lower half of the industry: CREX underperforms 65.26% of its industry peers.
The Return On Equity of CREX (-10.20%) is worse than 62.11% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.10%, CREX is in line with its industry, outperforming 44.21% of the companies in the same industry.
Industry RankSector Rank
ROA -4.16%
ROE -10.2%
ROIC 2.1%
ROA(3y)-0.1%
ROA(5y)-15.78%
ROE(3y)-0.07%
ROE(5y)-76.52%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 2.98%, CREX is not doing good in the industry: 63.16% of the companies in the same industry are doing better.
Looking at the Gross Margin, with a value of 49.12%, CREX is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
In the last couple of years the Gross Margin of CREX has grown nicely.
Industry RankSector Rank
OM 2.98%
PM (TTM) N/A
GM 49.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5Y1.56%

2

2. Health

2.1 Basic Checks

CREX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CREX has been increased compared to 1 year ago.
The number of shares outstanding for CREX has been increased compared to 5 years ago.
The debt/assets ratio for CREX has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.12, we must say that CREX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.12, CREX is not doing good in the industry: 74.74% of the companies in the same industry are doing better.
CREX has a debt to FCF ratio of 11.86. This is a negative value and a sign of low solvency as CREX would need 11.86 years to pay back of all of its debts.
CREX's Debt to FCF ratio of 11.86 is fine compared to the rest of the industry. CREX outperforms 61.05% of its industry peers.
CREX has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.34, CREX is doing good in the industry, outperforming 65.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 11.86
Altman-Z 0.12
ROIC/WACC0.23
WACC8.95%

2.3 Liquidity

A Current Ratio of 0.92 indicates that CREX may have some problems paying its short term obligations.
CREX has a worse Current ratio (0.92) than 82.11% of its industry peers.
CREX has a Quick Ratio of 0.92. This is a bad value and indicates that CREX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CREX (0.79) is worse than 82.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.79

6

3. Growth

3.1 Past

The earnings per share for CREX have decreased strongly by -204.41% in the last year.
CREX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.19%.
The Revenue has been growing by 14.97% on average over the past years. This is quite good.
EPS 1Y (TTM)-204.41%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q166.99%
Revenue 1Y (TTM)4.19%
Revenue growth 3Y37.27%
Revenue growth 5Y14.97%
Revenue growth Q2Q37.83%

3.2 Future

The Earnings Per Share is expected to grow by 77.92% on average over the next years. This is a very strong growth
CREX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.67% yearly.
EPS Next Y143.71%
EPS Next 2Y77.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year32.85%
Revenue Next 2Y24.67%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CREX. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 21.90, CREX is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as CREX.
CREX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.41.
Industry RankSector Rank
PE N/A
Fwd PE 21.9

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CREX.
CREX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 30.71
EV/EBITDA 9.99

4.3 Compensation for Growth

CREX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CREX's earnings are expected to grow with 77.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.92%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CREX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CREATIVE REALITIES INC

NASDAQ:CREX (5/3/2024, 7:00:01 PM)

3.35

+0.21 (+6.69%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap35.01M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.9
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.16%
ROE -10.2%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.98%
PM (TTM) N/A
GM 49.12%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.92
Quick Ratio 0.79
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-204.41%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y143.71%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.19%
Revenue growth 3Y37.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y